NCT03931590View on ClinicalTrials.gov

A Human AME Study for Omaveloxolone

PHASE1CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

April 11, 2019

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions

Healthy Male Subjects

Interventions

DRUG

[14C]-Omaveloxolone

\[14C\]-Omaveloxolone 50 mg capsules

Trial Locations (1)

53704

Covance Clinical Research Unit (CRU) Inc., Madison

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Biogen

INDUSTRY